Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Current Taxes (2021)

Mereo BioPharma (MREO) has disclosed Current Taxes for 1 consecutive years, with $2.1 million as the latest value for Q4 2021.

  • Quarterly Current Taxes changed N/A to $2.1 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2021, changed N/A year-over-year, with the annual reading at $2.1 million for FY2021, N/A changed from the prior year.
  • Current Taxes for Q4 2021 was $2.1 million at Mereo BioPharma.
  • The five-year high for Current Taxes was $2.1 million in Q4 2021, with the low at $2.1 million in Q4 2021.